Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03416348 · ClinicalTrials.gov registry record · Phase 1
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 95
- Enrollment target
NCT03416348 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 95 participants.
The verdict
NCT03416348, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 95 participants
- Enrollment target
Study Summary
The objective is to establish an evidence base for a hyperhidrosis treatment algorithm in amputees. This project will address a problem that has troubled Service members, Veterans, and civilians with amputations for decades, impacting satisfaction with prosthetic use, residual limb skin health, and negatively affecting quality of life. Prior research in this area has been limited and insufficient. The Investigators are confident that improving the evaluation and treatment of residual limb hyperhidrosis will reduce the secondary health consequences of amputation and will lead to improved quality of life. This will be accomplish by completing the following specific aims. Aim 1: Test the validity of the Minor iodine-starch test in amputees. Hypothesis: The iodine-starch test is a valid diagnostic tool of hyperhidrosis and can be useful for the identification of focal areas of sweating on a residual limb Aim 2: Test the effectiveness of a prescription strength topical antiperspirant (Aluminum Chloride 20%) on hyperhidrosis of the residual limb. Hypothesis: Aluminum Chloride will be more effective at controlling sweating than placebo
Interventions
- DRUG Alcohol
- DRUG Aluminum Chloride 20% (deodorant)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2018-05-08 |
| Est. Completion | 2022-02-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03416348
The ClinicalTrials.gov registry entry for NCT03416348 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alcohol is the first listed.
NCT03416348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03416348 about?
NCT03416348 is a clinical study titled "Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2". The objective is to establish an evidence base for a hyperhidrosis treatment algorithm in amputees. This project will address a problem that has troubled Service members, Veterans, and civilians with amputations for decades, impacting satisfaction with prosthetic use, residual limb skin health, and ...
What is the current status of trial NCT03416348?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 95 participants. The study started on 2018-05-08. Estimated completion is 2022-02-14.
What interventions are being tested in trial NCT03416348?
The interventions under investigation include: Alcohol (DRUG), Aluminum Chloride 20% (deodorant) (DRUG).
Who is sponsoring clinical trial NCT03416348?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.